KOOL vs. IINN, ONCT, XGN, GDTC, HLTH, CPIX, BIOR, BFRG, LUMO, and ZIVO
Should you be buying Cesca Therapeutics stock or one of its competitors? The main competitors of Cesca Therapeutics include Inspira Technologies Oxy B.H.N. (IINN), Oncternal Therapeutics (ONCT), Exagen (XGN), CytoMed Therapeutics (GDTC), Cue Health (HLTH), Cumberland Pharmaceuticals (CPIX), Biora Therapeutics (BIOR), Bullfrog AI (BFRG), Lumos Pharma (LUMO), and ZIVO Bioscience (ZIVO). These companies are all part of the "medical" sector.
Cesca Therapeutics (NASDAQ:KOOL) and Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.
Cesca Therapeutics has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500. Comparatively, Inspira Technologies Oxy B.H.N. has a beta of 2.13, suggesting that its share price is 113% more volatile than the S&P 500.
In the previous week, Inspira Technologies Oxy B.H.N. had 2 more articles in the media than Cesca Therapeutics. MarketBeat recorded 2 mentions for Inspira Technologies Oxy B.H.N. and 0 mentions for Cesca Therapeutics. Cesca Therapeutics' average media sentiment score of 0.00 equaled Inspira Technologies Oxy B.H.N.'saverage media sentiment score.
Inspira Technologies Oxy B.H.N. has lower revenue, but higher earnings than Cesca Therapeutics.
3.1% of Cesca Therapeutics shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies Oxy B.H.N. shares are owned by institutional investors. 68.9% of Cesca Therapeutics shares are owned by insiders. Comparatively, 29.4% of Inspira Technologies Oxy B.H.N. shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Inspira Technologies Oxy B.H.N. has a net margin of 0.00% compared to Cesca Therapeutics' net margin of -98.84%. Cesca Therapeutics' return on equity of -77.30% beat Inspira Technologies Oxy B.H.N.'s return on equity.
Cesca Therapeutics received 264 more outperform votes than Inspira Technologies Oxy B.H.N. when rated by MarketBeat users. However, 100.00% of users gave Inspira Technologies Oxy B.H.N. an outperform vote while only 70.45% of users gave Cesca Therapeutics an outperform vote.
Summary
Inspira Technologies Oxy B.H.N. beats Cesca Therapeutics on 6 of the 11 factors compared between the two stocks.
Get Cesca Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for KOOL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KOOL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cesca Therapeutics Competitors List
Related Companies and Tools
